Skip to main content
Glenda Callender, MD, General Surgery, Bridgeport, CT, Yale-New Haven Hospital

GlendaGraceCallenderMDFACS

General Surgery • Bridgeport, CT

Endocrine, Surgical Oncology (Other than Breast), Minimally Invasive Surgery

Associate Professor, Director of Endocrine Surgical Oncology Clinical Trials Section of Endocrine Surgery

Join to view full profile

Dr. Callender is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Callender's full profile

Already have an account?

Summary

  • Glenda G. Callender, M.D., FACS is a board-certified surgeon. She earned her medical degree from Harvard Medical School in 2000 and completed her residency at the University of Chicago Medical Center in 2007. Dr. Callender is fellowship-trained in Surgical Oncology and Surgical Endocrinology. She completed both fellowships in 2010 at M D Anderson Cancer Center.

    Her clinical interests include thyroid, parathyroid, and adrenal surgery. She focuses on minimally invasive approaches, and surgery for endocrine cancers. Her research focuses on outcomes of endocrine surgery, and clinical trials for endocrine cancers

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2009 - 2010
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Surgical Endocrinology, 2008 - 2009
  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2007 - 2008
  • University of Chicago
    University of ChicagoResidency, Surgery, 2000 - 2007
  • University of Chicago
    University of ChicagoInternship, Surgery, 2000 - 2001
  • Harvard Medical School
    Harvard Medical SchoolClass of 2000
  • University of Pennsylvania
    University of PennsylvaniaPost-baccalaureate, Pre-health program, 1996
  • University of Pennsylvania
    University of PennsylvaniaBA, Psychology with French minor, Summa cum laude, 1994

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2013 - 2025
  • KY State Medical License
    KY State Medical License 2010 - 2014
  • TX State Medical License
    TX State Medical License 2007 - 2011
  • IL State Medical License
    IL State Medical License 2000 - 2008
  • American Board of Surgery Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
  • Clinical Excellence Award for Graduating Fellows M. D. Anderson Cancer Center, 2010
  • Mid-Level Providers’ Appreciation Award M. D. Anderson Cancer Center, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • T cell receptor gene transfer: A potential novel therapy for Hepatitis C virus infection  
    Callender GG, Rosen HR, Leistikow R, Brown ME, Millis JM, McKee MD, Nishimura MI, Hepatology, 1/1/2004
  • Selection of HCV-specific CD8+ T cells by donor HLA alleles following liver transplantation  
    Rosen H, Hinrichs DJ, Leistikow R, Callender G, Nishimura MI, Lewinson D, Hepatology, 1/1/2004

Books/Book Chapters

  • Endocrinology, Adult and Pediatric 
    Chapter: Surgical management of hyperparathyroidism 
    Page 1135. - 1146.Callender GG, Carling T, Christison-Lagay E, Udelsman REditors: Jameson JL, De Groot LJ.Elsevier, PhiladelphiaEdition 7th,2016
  • Operative Techniques in Surgery 
    Chapter: Popliteal Dissection 
    Page 1634. - 1640.Callender GG, McMasters KM.Editors: Mulholland M, Hawn M, Hughes S, Albo D, Sabel M, Dalman R.Wolter Kluwers Health, Philadelphia2015
  • The Parathyroids 
    Chapter: Surgical management of primary hyperparathyroidism. 
    Page 519.0 - 532.0Callender GG, Carling T, Udelsman R.Editors: Bilezikian JP, Marcus R, Levine M, Marcocci C, Silverberg SJ and Potts JT.ElsevierEdition 3rd,2015
  • Join now to see all

Lectures

  • Age and Anti-thyroid Drug Intolerance Predict Definitive Therapy in Pediatric Graves Disease 
    Jacksonville, FL - 1/1/2016
  • Multiple Endocrine Neoplasia Syndromes 
    Bridgeport, CT - 1/1/2015
  • Dissection of Levels II through V is Required for Optimal Outcome in Patients with Lateral Neck Lymph Node Metastasis from Papillary Thyroid Carcinoma 
    Newport, RI - 1/1/2015
  • Join now to see all

Other

  • Recurrent/Persistent Primary Hyperparathyroidism 
    Callender GG, American College of Surgeons, SCORE Curriculum Module
    1/1/2012
  • National Cancer Institute (NCI), Physician Data Query (PDQ), Pheochromocytoma Treatment Health Professionals NCI Statement website work 
    Callender GG, Lee JE
    1/1/2010

Press Mentions

  • Women Surgeons Not Made Welcome
    Women Surgeons Not Made WelcomeJanuary 25th, 2020
  • Primary Hyperparathyroidism
    Primary HyperparathyroidismSeptember 13th, 2018

Professional Memberships

Hospital Affiliations

External Links

  • Yalehttp://surgery.yale.edu/endocrine/education/glenda_callender.profile

Dr. Glenda Callender, Dr. Glenda Callender, MD, Dr. G Callender, Dr. Glenda Grace Callender